Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC (RARE)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 01/18 04:00:00 pm
53.34 USD   +3.47%
2014Amid Alibaba fever, reasons for caution in IPO market
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

ULTRAGENYX PHARMACEUTICAL INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/05/2018 | 04:23pm EST

Item 2.02Results of Operations and Financial Condition.

On November 5, 2018, Ultragenyx Pharmaceutical Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2018 (the "Press Release"). A copy of the Press Release is furnished herewith as Exhibit 99.1.

The information set forth under Item 2.02 and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.       Description
99.1                Press Release of Ultragenyx Pharmaceutical Inc., dated
                  November 5, 2018






                                     * * *



                                     - 2 -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ULTRAGENYX PHARMACEUTICAL
01/15ULTRAGENYX PHARMACEUTICAL INC. : Entry into a Material Definitive Agreement (for..
AQ
01/07ULTRAGENYX PHARMACEUTICAL INC. : Regulation FD Disclosure, Other Events, Financi..
AQ
01/07Flurry of management moves on eve of JPM
AQ
01/05ULTRAGENYX PHARMACEUTICAL : Announces Positive Topline Results from First Cohort..
AQ
01/04Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 ..
GL
01/03Ultragenyx to Present at J.P. Morgan Healthcare Conference
GL
2018Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita (buros..
AQ
2018Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™..
GL
2018ULTRAGENYX PHARMACEUTICAL : Announces Intent to Submit New Drug Application to U..
AQ
2018ULTRAGENYX PHARMACEUTICAL INC. : Other Events, Financial Statements and Exhibits..
AQ
More news